Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study

Federico Cappuzzo, Tudor–Eliade Ciuleanu, Lilia V. Stelmakh et al. · The Lancet Oncology · 2010

Cited by 1,186 works. doi:10.1016/s1470-2045(10)70112-1

Authors

References